What is known about breast cancer in young women?

JW Zhu, P Charkhchi, S Adekunte, MR Akbari - Cancers, 2023 - mdpi.com
Simple Summary Breast cancer is the most common cancer affecting women under 40 years
of age worldwide, with an increasing number of cases diagnosed each year. Despite this …

Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology consensus guideline on margins for breast-conserving …

M Morrow, KJ Van Zee, LJ Solin… - Journal of Clinical …, 2016 - ascopubs.org
Background Controversy exists regarding the optimal negative margin width for ductal
carcinoma in situ (DCIS) treated with breast-conserving surgery and whole-breast irradiation …

Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline

BD Smith, JR Bellon, R Blitzblau, G Freedman… - Practical radiation …, 2018 - Elsevier
Introduction The purpose of this guideline is to offer recommendations on fractionation for
whole breast irradiation (WBI) with or without a tumor bed boost and guidance on treatment …

[HTML][HTML] The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results …

JS Haviland, JR Owen, JA Dewar, RK Agrawal… - The lancet …, 2013 - thelancet.com
Background 5-year results of the UK Standardisation of Breast Radiotherapy (START) trials
suggested that lower total doses of radiotherapy delivered in fewer, larger doses (fractions) …

Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: a randomized clinical trial

SF Shaitelman, PJ Schlembach, I Arzu, M Ballo… - JAMA …, 2015 - jamanetwork.com
Importance The most appropriate dose fractionation for whole-breast irradiation (WBI)
remains uncertain. Objective To assess acute and 6-month toxic effects and quality of life …

Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer

M Kaufmann, G Von Minckwitz, EP Mamounas… - Annals of surgical …, 2012 - Springer
The use of neoadjuvant systemic therapy (NST) for the treatment of primary breast cancer
has constantly increased, especially in trials of new therapeutic regimens. In the 1980 s …

The lancet breast cancer commission

CE Coles, H Earl, BO Anderson, CH Barrios, M Bienz… - The Lancet, 2024 - thelancet.com
Executive summary The Lancet Breast Cancer Commission—a diverse, multidisciplinary
international group—are unanimous in our determination to improve the lives of all people …

An update on the management of breast cancer in Africa

V Vanderpuye, S Grover, N Hammad… - Infectious agents and …, 2017 - Springer
Background There is limited information about the challenges of cancer management and
attempts at improving outcomes in Africa. Even though South and North Africa are better …

[HTML][HTML] Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial

RW Blamey, T Bates, U Chetty, SW Duffy, IO Ellis… - European journal of …, 2013 - Elsevier
BACKGROUND: The incidence of local recurrence (LR) after conservative surgery for early
breast cancer without adjuvant therapy is unacceptably high even with favourable tumours …

Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?

MK Thompson, P Poortmans, AJ Chalmers… - British journal of …, 2018 - nature.com
As we mark 150 years since the birth of Marie Curie, we reflect on the global advances
made in radiation oncology and the current status of radiation therapy (RT) research. Large …